Plaisance Capital LLC Crispr Therapeutics Ag Call Options Transaction History

Plaisance Capital LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $1.09 Million - $1.86 Million	-25,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $1.34 Million - $2 Million	25,200 New	25,200 $1.58 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $280,360 - $445,160	-4,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $403,360 - $647,560	4,000 New	4,000 $484,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Plaisance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Plaisance Capital LLC with notifications on news.